Oricell Therapeutics: Pre-IPODevelops next-generation cell therapies for oncology and immunologyOct 4, 2026RoundOSOricell TherapeuticsCompany profile and funding historyPrevious roundsSeries C1 · $70MJan 12, 2026Sourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechChinaHealthtechAsiaUndisclosed